Analysis of cell movement using label-free phase-contrast microscopy enables differentiation between healthy fibroblasts and cancerous fibrosarcoma cells with up to 94% accuracy.

Now phase-contrast microscopy, interference microscopy, Schlieren and dark-ground illumination are essentially methods for revealing small variations in refractive index (or strictly, optical path).

Currently, there is no FDA approved right heart contrast agent." said Morgan Evans, CEO of Agitated Solutions. "This IND clearance is a significant milestone, allowing us to begin our Phase 3 ...

The biotech linked BNT327 to a median overall survival (OS) of 16.8 months in a Chinese phase 2 trial, suggesting the drug candidate could set a new benchmark in a market served by AstraZeneca and ...

When all you’ve got is a hammer, everything looks like a nail. And when you’ve got a scanning electron microscope, everything must look like a sample that would be really, really interesting ...

(CNN) — The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release ...

These include the ZEISS ARTEVO 850 and ARTEVO 750 ophthalmic microscopes, the AT ELANA® 841P trifocal Intraocular Lens (IOL), and the ZEISS CIRRUS PathFinder AI decision support tool - all ...

The high-end Swiss watch lent a striking contrast to Noem’s tour of the Terrorism Confinement Center, or CECOT, where imprisoned men watched silently from a crowded cell as she recorded a video ...